TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

Innovators in Biotech

Medical researcher conducting pharmaceutical research in a lab. Representing innovation in biotech.
Insight by

Yaron Werber, Biotechnology Analyst, interviewed management teams from four biotech companies about opportunities, challenges, and the reimbursement outlook when launching innovative therapies for oncology & immunology. They discuss the importance of innovation and differentiation when launching new products, global drug pricing, and the looming impact of the Inflation Reduction Act.

Interviewees include:

Murdo Gordon, Executive VP Global Commercial Operations, Amgen

Keith Woods, COO, Argenx

Josh Neiman, SVP, Chief Commercial Officer – North America & Europe, Beigene

Ying Huang, Ph.D., CEO, Legend Biotech

Get the Full Report

If you’re already a member of our Research portal, log in.

Log In